Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9
|
| pubmed:dateCreated |
1995-11-3
|
| pubmed:abstractText |
In a confirmatory laboratory, the second-generation recombinant immunoblot assay (RIBA-2) was replaced by the third-generation RIBA (RIBA-3) in March 1993. The aim of this validation study was to compare the sensitivity and specificity of RIBA-2 and RIBA-3 in a routine setting, by using a validated hepatitis C virus (HCV) RNA polymerase chain reaction to establish plasma viremia.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0041-1132
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
35
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
745-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:7570934-Hepacivirus,
pubmed-meshheading:7570934-Hepatitis C,
pubmed-meshheading:7570934-Humans,
pubmed-meshheading:7570934-Immunoblotting,
pubmed-meshheading:7570934-Polymerase Chain Reaction,
pubmed-meshheading:7570934-Recombinant Proteins,
pubmed-meshheading:7570934-Sensitivity and Specificity
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus.
|
| pubmed:affiliation |
Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam.
|
| pubmed:publicationType |
Journal Article,
Comparative Study
|